lansoprazole has been researched along with Anoxemia in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Alwis, N | 1 |
| Beard, S | 1 |
| Binder, NK | 1 |
| Pritchard, N | 1 |
| Tong, S | 1 |
| Kaitu'u-Lino, TJ | 1 |
| Hannan, NJ | 1 |
1 other study available for lansoprazole and Anoxemia
| Article | Year |
|---|---|
Placental DAAM2 is unaltered in preeclampsia, but upregulated by treatment with proton pump inhibitors.
Topics: Antioxidants; Esomeprazole; Female; Humans; Hypoxia; Infant, Newborn; Lansoprazole; Microfilament Pr | 2022 |